17, 2012 /PRNewswire/ -- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a Series B financing led by new investor Baxter Ventures.
URL: http://www.topix.com/health/depression/2012/12/naurex-inc-completes-38-million-series-b-financing?fromrss=1
No comments:
Post a Comment